References
1. Lu, H.Y., et al., Contribution of Histologic Chorioamnionitis and Fetal Inflammatory Response Syndrome to Increased Risk of Brain Injury in Infants With Preterm Premature Rupture of Membranes. Pediatr Neurol, 2016. 61 : p. 94-98.e1.
2. Lorthe, E., et al., Impact of Latency Duration on the Prognosis of Preterm Infants after Preterm Premature Rupture of Membranes at 24 to 32 Weeks’ Gestation: A National Population-Based Cohort Study. J Pediatr, 2017. 182 : p. 47-52.e2.
3. Tita, A.T. and W.W. Andrews, Diagnosis and management of clinical chorioamnionitis. Clin Perinatol, 2010. 37 (2): p. 339-54.
4. Been, J.V., et al., Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol, 2009. 201 (6): p. 587.e1-8.
5. Park, C.W., et al., The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications. Placenta, 2009. 30 (1): p. 56-61.
6. Lahra, M.M. and H.E. Jeffery, A fetal response to chorioamnionitis is associated with early survival after preterm birth.Am J Obstet Gynecol, 2004. 190 (1): p. 147-51.
7. Edwards, R.K. and P. Duff, Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol, 2003.102 (5 Pt 1): p. 957-61.
8. Kim, S.A., K.H. Park, and S.M. Lee, Non-Invasive Prediction of Histologic Chorioamnionitis in Women with Preterm Premature Rupture of Membranes. Yonsei Med J, 2016. 57 (2): p. 461-8.
9. Goldenberg, R.L., et al., Epidemiology and causes of preterm birth. Lancet, 2008. 371 (9606): p. 75-84.
10. Goldenberg, R.L. and L.L. Wright, Repeated courses of antenatal corticosteroids. Obstet Gynecol, 2001. 97 (2): p. 316-7.
11. Danesh, A., M. Janghorbani, and S. Khalatbari, Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone. J Res Med Sci, 2012. 17 (10): p. 911-7.
12. Bauer, M.E., et al., Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis().J Obstet Gynaecol, 2018. 38 (2): p. 210-216.
13. Voon, H.Y., et al., Corticosteroid-induced leukocytosis in pregnancy: A prospective observational study. Med J Malaysia, 2017.72 (5): p. 259-263.
14. Hu, Y., et al., Establishment of reference intervals for procalcitonin in healthy pregnant women of Chinese population. Clin Biochem, 2017. 50 (3): p. 150-154.
15. Areia, A.L., M. Areia, and A. Mota-Pinto, Procalcitonin in preterm rupture of membranes: a systematic review and meta-analysis.Arch Gynecol Obstet, 2021. 303 (4): p. 917-924.
16. Thornburg, L.L., et al., Procalcitonin for prediction of chorioamnionitis in preterm premature rupture of membranes. J Matern Fetal Neonatal Med, 2016. 29 (13): p. 2056-61.
17. Li, K., et al., Predictive value of procalcitonin or c-reactive protein for subclinical intrauterine infection in patients with premature rupture of membranes (PROM). J Prenat Med, 2016.10 (3-4): p. 23-28.
18. Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol, 2020. 135 (3): p. e80-e97.
19. Yoon, B.H., et al., Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol, 1995. 172 (3): p. 960-70.
20. Asadi, N., et al., Predictive value of procalcitonin, C-reactive protein, and white blood cells for chorioamnionitis among women with preterm premature rupture of membranes. Int J Gynaecol Obstet, 2019. 147 (1): p. 83-88.
21. Erdemir, G., et al., Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol, 2013.54 (4): p. 267-74.
22. Cobo, T., et al., A prediction model of histological chorioamnionitis and funisitis in preterm prelabor rupture of membranes: analyses of multiple proteins in the amniotic fluid. J Matern Fetal Neonatal Med, 2012. 25 (10): p. 1995-2001.
23. Elimian, A., et al., Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol, 2000. 96 (3): p. 333-6.
24. Denison, F.C., C.L. Elliott, and E.M. Wallace,Dexamethasone-induced leucocytosis in pregnancy. Br J Obstet Gynaecol, 1997. 104 (7): p. 851-3.